Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study
一项随机、3期研究(CLEAR):比较乐伐替尼联合帕博利珠单抗或依维莫司治疗晚期肾细胞癌患者的健康相关生活质量结局与舒尼替尼单药治疗的疗效。
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(22)00212-1
Motzer, Robert; Porta, Camillo; Alekseev, Boris; Rha, Sun Young; Choueiri, Toni K; Mendez-Vidal, Maria Jose; Hong, Sung-Hoo; Kapoor, Anil; Goh, Jeffrey C; Eto, Masatoshi; Bennett, Lee; Wang, Jinyi; Pan, Jie Janice; Saretsky, Todd L; Perini, Rodolfo F; He, Cixin Steven; Mody, Kalgi; Cella, David